| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| —— | N-(2-(5-hydroxyindol-3-yl)ethyl)-3-propanamide | —— | C13H16N2O2 |
| —— | 4-methyl-7-oxo-2,6-diphenyl-5,6-diazaspiro[2.4]hept-4-ene-1,1-dicarbonitrile | —— | C20H14N4O |
| —— | 3,3',3''-trimethyl-1,1',1"-triphenylmethyl-4,4',4''-tris(2-pyrazoline-5-one) | —— | C30H26N6O3 |
| —— | 5-(Nonyloxy)tryptamine hydrochloride | 171783-23-6 | C19H30N2O*ClH |
| —— | N-(2-(5-hydroxy-1H-indol-3-yl)ethyl)formamide | —— | C11H12N2O2 |
| —— | (9Z,12S)-12-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]octadec-9-enamide | —— | C28H44N2O3 |
| —— | 17β-(isobutylcarbonyl)-androsta-3,5-diene-3-carboxylic acid | —— | C25H36O3 |
| —— | 17β-benzoyl-androsta-3,5-diene-3-carboxylic acid | —— | C27H32O3 |
| —— | 12-Hydroxy-octadecenoic acid | —— | C18H34O3 |
| —— | (E)-ethyl 2-(1-benzyl-2-oxoindolin-3-ylidene)acetate | —— | C19H17NO3 |
| —— | 17β-(4-fluorophenethylcarbonyl)-androst-3,5-diene-3-carboxylic acid | —— | C29H35FO3 |
| —— | 17β-{N-[1-(3,4-Dimethoxyphenyl)-1-methylethyl]carbamoyl}androsta-3,5-diene-3-carboxylic acid | —— | C32H43NO5 |
| —— | 12-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]octadec-9-enamide | —— | C28H44N2O3 |
| —— | 17β-(benzylcarbonyl)-androsta-3,5-diene-3-carboxylic acid | —— | C28H34O3 |
| —— | 4-(3'-pentyl-[1,1'-biphenyl]-3-yl)butanoic acid | —— | C21H26O2 |
| —— | 17β-(3-(4-methoxy phenyl)-1-oxopropyl)-androsta-3,5-diene-3-carboxylic acid | —— | C30H38O4 |
| —— | N-(2-(1-acetyl-5-hydroxy-1H-indol-3-yl)ethyl)acetamide | —— | C14H16N2O3 |
| —— | (S)-N-((3-(3-fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamidehydrochloride | —— | C16H21FN4O3*ClH |
| —— | 5-(4'-bromobenzyloxy)-4-oxo-4H-chromene-2-carboxylic acid [2-(5-hydroxy-1H-indol-3-yl)ethyl]amide | —— | C27H21BrN2O5 |
| —— | N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(2,4-dihydroxyphenyl)-2-propenamide | —— | C19H18N2O4 |
| —— | n-Propyl 2-(4',6'-dimethoxypyrimidine-2'-yl)oxy-benzoate | —— | C16H18N2O5 |
| —— | 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-[1,2,4]-triazolo[4,3-a]pyrazine formate | —— | (x)CH2O2*C16H15F6N5O |
| —— | N-(p-methoxycinnamoyl)serotonin | —— | C20H20N2O3 |
| —— | 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-[1,2,4]-triazolo[4,3-a]pyrazine cinnamate | —— | (x)C9H8O2*C16H15F6N5O |
| —— | sodium ((4-iodo-6-methoxypyrimidin-2-yl)carbamoyl)((2-(propoxycarbonyl) phenoxy)sulfonyl)amide | —— | C16H16IN4O7S*Na |
| —— | (3R)-3-amino-1-[9-(trifluoromethyl)-1,4,7,8-tetrazabicyclo[4.3.0]nona-6,8-dien-4-yl]-4-(2,4,5-trifluorophenyl)butan-1-one (R)-1,2-dithiacyclopentane-3-valerate | —— | (x)C8H14O2S2*C16H15F6N5O |
| —— | (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-α]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine p-toluenesulfonate | —— | C7H8O3S*C16H15F6N5O |
| —— | sodium ((4-bromo-6-methoxypyrimidin-2-yl)carbamoyl)((2-(propoxycarbonyl)phenoxy)sulfonyl)amide | —— | C16H16BrN4O7S*Na |
| —— | 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-[1,2,4]-triazolo[4,3-a]pyrazine picolinate | —— | (x)C6H5NO2*C16H15F6N5O |
| —— | Propyl 2-[(6,7-dimethoxy-4-quinolyl)oxy]benzoate | —— | C21H21NO5 |
| —— | rac-(5aS,13bR)-1,9-dimethyl-3-phenyl-3,5a,6,13b-tetrahydro-5H-pyrazolo[4'',3'':5',6']pyrano[4',3':4,5]thiopyrano[2,3-b]quinoline | —— | C24H21N3OS |
| —— | 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-[1,2,4]-triazolo[4,3-a]pyrazine nitrate | —— | C16H15F6N5O*(x)HNO3 |
| —— | rac-(2aR,10cS)-7,11-dimethyl-13-phenyl-2a,3,10c,13-tetrahydro-2H,9H-pyrano[2'',3'':5',6']chromeno[4',3':4,5]pyrano[2,3-c]pyrazol-9-one | —— | C24H20N2O4 |
| —— | sitagliptin caprate | —— | (x)C10H20O2*C16H15F6N5O |
| —— | sitagliptin caffate | —— | (x)C9H8O4*C16H15F6N5O |
| —— | rac-(5aR,13bS)-1,5,5,9-tetramethyl-3-phenyl-3,5a,6,13b-tetrahydro-5H-pyrazolo[4'',3'':5',6']pyrano[4',3':4,5]thiopyrano[2,3-b]quinoline | —— | C26H25N3OS |
| —— | (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine trifluoroacetic acid | —— | C2HF3O2*C16H15F6N5O |
| —— | 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-[1,2,4]-triazolo[4,3-a]pyrazine nicotinate | —— | (x)C6H5NO2*C16H15F6N5O |
| —— | (2,4,5-trifluorophenyl)oxoacetic acid | 1702443-94-4 | C8H3F3O3 |
| —— | 2,4,5-trifluorobenzene-1-carbonyl cyanide | 2091697-40-2 | C8H2F3NO |
| —— | (2S,6'R)-2'-(benzyloxy)-7-chloro-4-(difluoromethoxy)-6-methoxy-6'-methyl-3H-spiro[benzofuran-2,1'-cyclohexan]-2'-ene-3,4'-dione | —— | C23H19ClF2O6 |
| —— | acetaldehyde cation radical | —— | C2H4O |
| —— | (1'S,6'R)-7-chloro-4,6-dimethoxy-6'-methyl-3'-(phenylsulfinyl)-3H-spiro[benzofuran-2,1'-cyclohex[2]ene]-3,4'-dione | —— | C22H19ClO6S |
| —— | (2S,6'R)-2'-(benzyloxy)-7-chloro-6-(difluoromethoxy)-4-methoxy-6'-methyl-3H-spiro[benzofuran-2,1'-cyclohexan]-2'-ene-3,4'-dione | —— | C23H19ClF2O6 |
| —— | [2-(4-methoxy-phenyl)-1-methyl-ethyl]-(1-phenyl-ethyl)-amine | —— | C18H23NO |
| —— | 3-methyl-1-phenyl-1H-pyrazol-5-yl 4-fluorobenzenesulfonate | —— | C16H13FN2O3S |
| —— | 3-methyl-4-((1-methyl-1H-indol-3-yl)methylene)-1-phenyl-1H-pyrazol-5(4H)-one | —— | C20H17N3O |
| —— | sitagliptin hydrochloride monohydrate | 862156-92-1 | C16H15F6N5O*ClH*H2O |
| —— | (3-bromo-phenyl)-(7,8,10,11-tetrahydro-6,9,12-trioxa-1,3-diaza-cyclonona[b]naphthalen-4-yl)-amine | —— | C18H16BrN3O3 |
| —— | (8,9-dihydro-7H-[1,4]dioxepino[2,3-g]quinazolin-4-yl)-(3'-bromophenyl)amine | —— | C17H14BrN3O2 |